A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer’s Disease
Condition(s):Psychosis Associated With Alzheimer’s DiseaseLast Updated:March 4, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Psychosis Associated With Alzheimer’s DiseaseLast Updated:March 4, 2024Recruiting
Condition(s):Psychosis Associated With Alzheimer’s DiseaseLast Updated:February 2, 2024Enrolling by invitation
Condition(s):SchizophreniaLast Updated:March 4, 2024Recruiting
Condition(s):SchizophreniaLast Updated:July 7, 2023Terminated
Condition(s):Psychosis Associated With Alzheimer’s DiseaseLast Updated:March 4, 2024Recruiting
Condition(s):SchizophreniaLast Updated:March 22, 2024Enrolling by invitation
Condition(s):SchizophreniaLast Updated:March 22, 2024Recruiting
Condition(s):SchizophreniaLast Updated:August 16, 2023Active, not recruiting
Condition(s):Schizophrenia; Schizophrenia; PsychosisLast Updated:October 31, 2023Completed
Condition(s):SchizophreniaLast Updated:November 29, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.